Health Care & Life Sciences » Pharmaceuticals | TESARO Inc.

TESARO Inc.

TESARO Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 54.91 M
Public Float
 16.79 M
TESARO Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $9.84
Market Cap
 $1.93 B
Shares Outstanding
 54.91 M
Public Float
 38.27 M

Profile

Address
1000 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.tesarobio.com
Updated 09/14/2018
TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr.

Financials

View All
Created with Highcharts 5.0.14TESARO Inc.Net Income. Fiscal year is January-December. All values USD Thousands.92 36292 362171 012171 012251 408251 408374 224374 224496 126496 126201320142015201620170100k200k300k400k500k600k
Created with Highcharts 5.0.14TESARO Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.000031731758 01858 018223 326223 32620132014201520162017050k100k150k200k250k

Leon O. Moulder
Chief Executive Officer & Director
Mary Lynne Hedley
President, Chief Operating Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.